Search results
Baseball team raises money to help teen in her fight against cancer
KCRG-TV9 Cedar Rapids· 5 days agoEPWORTH, Iowa (KCRG) -For the past four years, the semi-pro baseball team the Epworth Orioles have...
Childhood cancer survivor and her family will host golf outing fundraiser for Make-A-Wish
The Sheboygan Press via Yahoo News· 3 days agoThere, she underwent a bone marrow biopsy. Olivia was diagnosed with acute lymphoblastic leukemia in...
Team Beachcomber rides PMC in honor of Calista Scribner as she valiantly fights leukemia
Homenewshere.com· 6 days agoA “warrior” is what her mother Jenn calls her brave daughter after she has been fighting a blood...
EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for...
FOX 59 Indianapolis· 22 hours agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the ...
Metis Global Partners LLC Sells 549 Shares of Incyte Co. (NASDAQ:INCY)
ETF DAILY NEWS· 6 days agoMetis Global Partners LLC lessened its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 6.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned ...
Cost and Kymriah: Financial assistance options, savings, more
Medical News Today· 6 days agoKymriah (tisagenlecleucel) is a brand-name intravenous (IV) infusion prescribed for certain blood...
Q3 2024 EPS Estimates for Beam Therapeutics Inc. Boosted by Analyst (NASDAQ:BEAM)
ETF DAILY NEWS· 6 days agoBeam Therapeutics Inc. (NASDAQ:BEAM – Free Report) – Research analysts at Leerink Partnrs upped their Q3 2024 EPS estimates for Beam Therapeutics in a research report issued on Tuesday, May ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 2 days agoVincerx continued to progress Phase 1 dose-escalation studies for VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC), and VIP236, a first-in-class small molecule-drug conjugate (SMDC) The National Institutes of Health
FY2024 EPS Estimates for Beam Therapeutics Inc. (NASDAQ:BEAM) Cut by Cantor Fitzgerald
ETF DAILY NEWS· 2 days agoBeam Therapeutics Inc. (NASDAQ:BEAM – Free Report) – Equities researchers at Cantor Fitzgerald cut their FY2024 EPS estimates for shares of Beam Therapeutics in a research note issued to investors ...
BNP Paribas Financial Markets Acquires 26,818 Shares of Incyte Co. (NASDAQ:INCY)
ETF DAILY NEWS· 2 days agoBNP Paribas Financial Markets boosted its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 9.7% during the fourth quarter, according to the company in its most recent filing with ...